 Andrew Bradford
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 7 | 2021 | 198 | 1.730 |
Why?
| | Follicle Stimulating Hormone | 13 | 2023 | 244 | 1.630 |
Why?
| | E2F1 Transcription Factor | 10 | 2025 | 64 | 1.630 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 185 | 1.480 |
Why?
| | Prolactin | 10 | 2022 | 100 | 1.070 |
Why?
| | Hyperlipidemias | 3 | 2022 | 120 | 1.020 |
Why?
| | Hyperinsulinism | 3 | 2022 | 121 | 1.000 |
Why?
| | Obesity | 16 | 2024 | 2966 | 0.990 |
Why?
| | Leiomyoma | 3 | 2019 | 76 | 0.970 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 108 | 0.940 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 38 | 0.900 |
Why?
| | Metabolic Syndrome | 4 | 2024 | 348 | 0.830 |
Why?
| | Pituitary Gland | 7 | 2021 | 149 | 0.830 |
Why?
| | Promoter Regions, Genetic | 17 | 2025 | 1255 | 0.800 |
Why?
| | Human Growth Hormone | 1 | 2022 | 46 | 0.750 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 646 | 0.730 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1769 | 0.720 |
Why?
| | Corpus Luteum | 3 | 2016 | 20 | 0.720 |
Why?
| | Soybean Oil | 1 | 2021 | 14 | 0.720 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 49 | 0.710 |
Why?
| | Gene Expression Regulation, Neoplastic | 10 | 2025 | 1400 | 0.680 |
Why?
| | Phospholipids | 2 | 2021 | 223 | 0.660 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 28 | 0.630 |
Why?
| | Cell Proliferation | 8 | 2024 | 2471 | 0.570 |
Why?
| | Insulin | 5 | 2022 | 2389 | 0.540 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 171 | 0.530 |
Why?
| | Apoptosis | 11 | 2024 | 2542 | 0.530 |
Why?
| | Gene Expression Regulation | 11 | 2023 | 2615 | 0.510 |
Why?
| | Diet, High-Fat | 3 | 2024 | 248 | 0.500 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.490 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.480 |
Why?
| | Signal Transduction | 11 | 2021 | 5077 | 0.470 |
Why?
| | Weight Gain | 2 | 2016 | 518 | 0.470 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 56 | 0.460 |
Why?
| | Gene Products, tax | 2 | 2024 | 13 | 0.450 |
Why?
| | Human T-lymphotropic virus 1 | 2 | 2024 | 28 | 0.450 |
Why?
| | DEAD-box RNA Helicases | 2 | 2025 | 76 | 0.450 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 87 | 0.430 |
Why?
| | Dietary Fats | 1 | 2015 | 301 | 0.420 |
Why?
| | Adenocarcinoma | 3 | 2009 | 934 | 0.400 |
Why?
| | Transcription Factors | 8 | 2018 | 1715 | 0.390 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 322 | 0.390 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1271 | 0.380 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1502 | 0.370 |
Why?
| | Cell Line, Tumor | 12 | 2025 | 3396 | 0.360 |
Why?
| | Gonadotropins | 3 | 2023 | 40 | 0.360 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 53 | 0.360 |
Why?
| | MicroRNAs | 2 | 2015 | 703 | 0.360 |
Why?
| | E2F Transcription Factors | 4 | 2023 | 60 | 0.360 |
Why?
| | Protein Kinase C | 2 | 2003 | 265 | 0.350 |
Why?
| | Cross-Over Studies | 3 | 2022 | 561 | 0.350 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.340 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 504 | 0.330 |
Why?
| | Estradiol | 5 | 2023 | 513 | 0.320 |
Why?
| | Female | 36 | 2024 | 72703 | 0.310 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 163 | 0.300 |
Why?
| | Transcriptional Activation | 4 | 2024 | 379 | 0.300 |
Why?
| | Hydrocortisone | 2 | 2022 | 317 | 0.280 |
Why?
| | RNA, Messenger | 2 | 2015 | 2837 | 0.280 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 531 | 0.280 |
Why?
| | Retinoblastoma Protein | 2 | 2025 | 57 | 0.270 |
Why?
| | Humans | 47 | 2025 | 136899 | 0.260 |
Why?
| | Menstrual Cycle | 2 | 2019 | 131 | 0.260 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 562 | 0.250 |
Why?
| | Growth Hormone | 3 | 2022 | 101 | 0.250 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 86 | 0.250 |
Why?
| | Isoenzymes | 3 | 2003 | 305 | 0.240 |
Why?
| | Weight Loss | 2 | 2024 | 765 | 0.230 |
Why?
| | Cytokines | 4 | 2024 | 2078 | 0.230 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 614 | 0.230 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 27 | 0.220 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 950 | 0.220 |
Why?
| | Adipokines | 1 | 2024 | 49 | 0.220 |
Why?
| | Live Birth | 1 | 2024 | 65 | 0.210 |
Why?
| | Phosphorylation | 5 | 2024 | 1762 | 0.210 |
Why?
| | Preconception Care | 1 | 2024 | 43 | 0.210 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2024 | 132 | 0.210 |
Why?
| | Persian Gulf Syndrome | 1 | 2023 | 17 | 0.210 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 121 | 0.210 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 56 | 0.210 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.200 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 206 | 0.200 |
Why?
| | Fertility | 1 | 2024 | 160 | 0.200 |
Why?
| | Pituitary Hormones | 1 | 2022 | 16 | 0.200 |
Why?
| | Mindfulness | 1 | 2024 | 121 | 0.190 |
Why?
| | Thyroid Hormones | 1 | 2022 | 58 | 0.190 |
Why?
| | Rats | 10 | 2006 | 5675 | 0.190 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 27 | 0.190 |
Why?
| | Thyrotropin | 1 | 2022 | 114 | 0.190 |
Why?
| | Hypothalamus | 2 | 2014 | 153 | 0.190 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1458 | 0.190 |
Why?
| | Animals | 19 | 2016 | 36915 | 0.180 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 270 | 0.180 |
Why?
| | Emulsions | 1 | 2021 | 54 | 0.180 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 533 | 0.180 |
Why?
| | Gastrointestinal Diseases | 1 | 2023 | 208 | 0.170 |
Why?
| | Thinness | 1 | 2021 | 91 | 0.170 |
Why?
| | Leptin | 1 | 2022 | 233 | 0.170 |
Why?
| | Heparin | 1 | 2022 | 259 | 0.170 |
Why?
| | Gastroesophageal Reflux | 1 | 2023 | 235 | 0.170 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 159 | 0.170 |
Why?
| | Wnt Proteins | 1 | 2021 | 133 | 0.170 |
Why?
| | Adiponectin | 1 | 2022 | 241 | 0.170 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 15 | 0.170 |
Why?
| | Creatinine | 1 | 2022 | 500 | 0.170 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 170 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 943 | 0.170 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 25 | 0.160 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2009 | 816 | 0.160 |
Why?
| | Adult | 17 | 2024 | 37595 | 0.160 |
Why?
| | Lipids | 2 | 2022 | 664 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 316 | 0.160 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 19 | 0.160 |
Why?
| | Cell Cycle | 2 | 2015 | 601 | 0.160 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 68 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 193 | 0.160 |
Why?
| | beta Catenin | 1 | 2021 | 251 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 39 | 0.150 |
Why?
| | Biomarkers | 2 | 2024 | 4148 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 156 | 0.150 |
Why?
| | Follicular Phase | 2 | 2015 | 39 | 0.150 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 83 | 0.150 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 329 | 0.150 |
Why?
| | Estrogens | 3 | 2019 | 358 | 0.150 |
Why?
| | Estrone | 2 | 2015 | 37 | 0.140 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 39 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 197 | 0.140 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 219 | 0.140 |
Why?
| | Etoposide | 2 | 2009 | 152 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 20 | 0.130 |
Why?
| | Pregnancy | 4 | 2024 | 6715 | 0.130 |
Why?
| | Fibroblasts | 3 | 2018 | 990 | 0.130 |
Why?
| | Aromatase | 2 | 2014 | 32 | 0.130 |
Why?
| | Oncogene Proteins | 1 | 1996 | 59 | 0.130 |
Why?
| | Genes, ras | 2 | 1997 | 96 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2024 | 1112 | 0.120 |
Why?
| | Blotting, Western | 2 | 2009 | 1227 | 0.120 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.120 |
Why?
| | Young Adult | 10 | 2024 | 13157 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 424 | 0.120 |
Why?
| | Cumulus Cells | 1 | 2015 | 6 | 0.120 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 97 | 0.120 |
Why?
| | Dietary Supplements | 2 | 2019 | 560 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1484 | 0.120 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 843 | 0.110 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 41 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 188 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 366 | 0.110 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 98 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1945 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 138 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2014 | 34 | 0.110 |
Why?
| | Luteal Phase | 1 | 2014 | 45 | 0.110 |
Why?
| | Hypogonadism | 3 | 2024 | 88 | 0.110 |
Why?
| | Transfection | 3 | 2009 | 948 | 0.110 |
Why?
| | Circadian Rhythm | 1 | 2017 | 463 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1997 | 424 | 0.100 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 176 | 0.100 |
Why?
| | RNA Interference | 2 | 2018 | 463 | 0.100 |
Why?
| | Postmenopause | 1 | 2015 | 361 | 0.100 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 48 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 2015 | 0.100 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 26 | 0.100 |
Why?
| | Base Sequence | 3 | 2012 | 2180 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 620 | 0.100 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2243 | 0.090 |
Why?
| | DNA, Complementary | 2 | 2012 | 269 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2847 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 328 | 0.090 |
Why?
| | Veterans | 1 | 2023 | 1446 | 0.090 |
Why?
| | Testosterone | 1 | 2015 | 398 | 0.090 |
Why?
| | Pulsatile Flow | 1 | 2011 | 60 | 0.090 |
Why?
| | Protein Isoforms | 2 | 2003 | 403 | 0.090 |
Why?
| | Cell Survival | 2 | 2021 | 1122 | 0.090 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 189 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 974 | 0.080 |
Why?
| | Neoplasms | 2 | 2023 | 2655 | 0.080 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 91 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 517 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 3948 | 0.080 |
Why?
| | Infertility, Female | 2 | 2024 | 108 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 75 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 72 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 151 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 480 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 82 | 0.080 |
Why?
| | Progesterone | 3 | 2016 | 251 | 0.080 |
Why?
| | Inflammation | 2 | 2024 | 2817 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 765 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 67 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1774 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2009 | 101 | 0.080 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 144 | 0.080 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2015 | 1167 | 0.080 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 162 | 0.070 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 82 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 536 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 283 | 0.070 |
Why?
| | Myometrium | 1 | 2008 | 40 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 398 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1460 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 165 | 0.070 |
Why?
| | Mice, Nude | 1 | 2009 | 696 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 792 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2009 | 466 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 510 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 514 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 123 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 437 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 82 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 69 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 45 | 0.070 |
Why?
| | HeLa Cells | 2 | 2000 | 640 | 0.070 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 64 | 0.070 |
Why?
| | Immunoprecipitation | 1 | 2006 | 155 | 0.060 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 99 | 0.060 |
Why?
| | DNA Damage | 1 | 2009 | 420 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 389 | 0.060 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 24 | 0.060 |
Why?
| | raf Kinases | 1 | 2006 | 13 | 0.060 |
Why?
| | Autocrine Communication | 1 | 2006 | 41 | 0.060 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 55 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 33118 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 182 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2006 | 64 | 0.060 |
Why?
| | Prostate | 1 | 2007 | 175 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 919 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 247 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 190 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 203 | 0.060 |
Why?
| | ras Proteins | 1 | 2006 | 151 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 196 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7543 | 0.060 |
Why?
| | Adolescent | 7 | 2021 | 21402 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2222 | 0.060 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| | Mice | 4 | 2012 | 17775 | 0.060 |
Why?
| | Cell Movement | 1 | 2009 | 971 | 0.060 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.060 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.060 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 316 | 0.060 |
Why?
| | Ovulation Induction | 2 | 2015 | 54 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 39 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 55 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2007 | 615 | 0.060 |
Why?
| | Body Mass Index | 3 | 2021 | 2351 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 84 | 0.050 |
Why?
| | Diet, Fat-Restricted | 1 | 2024 | 79 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 65 | 0.050 |
Why?
| | Thiocarbamates | 1 | 2003 | 6 | 0.050 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 7 | 0.050 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 14 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1505 | 0.050 |
Why?
| | Thiones | 1 | 2003 | 14 | 0.050 |
Why?
| | Norbornanes | 1 | 2003 | 15 | 0.050 |
Why?
| | Culturally Competent Care | 1 | 2024 | 61 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Chromones | 1 | 2003 | 44 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 12 | 0.050 |
Why?
| | Gulf War | 1 | 2023 | 15 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 103 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1739 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 370 | 0.050 |
Why?
| | Androstadienes | 1 | 2003 | 107 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 290 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 338 | 0.050 |
Why?
| | Morpholines | 1 | 2003 | 126 | 0.050 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 2901 | 0.050 |
Why?
| | Cluster Analysis | 2 | 2015 | 502 | 0.050 |
Why?
| | Acetophenones | 1 | 2001 | 13 | 0.050 |
Why?
| | Models, Molecular | 1 | 2007 | 1586 | 0.050 |
Why?
| | Benzopyrans | 1 | 2001 | 25 | 0.050 |
Why?
| | Focus Groups | 1 | 2024 | 500 | 0.050 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 31 | 0.040 |
Why?
| | Naphthalenes | 1 | 2001 | 58 | 0.040 |
Why?
| | Carbazoles | 1 | 2001 | 83 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 31 | 0.040 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 30 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 514 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 307 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 69 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 377 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 193 | 0.040 |
Why?
| | Genetic Fitness | 1 | 2021 | 57 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 395 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 194 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 108 | 0.040 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 142 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 685 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 244 | 0.040 |
Why?
| | Aged | 1 | 2019 | 23641 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 658 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 344 | 0.040 |
Why?
| | DNA | 2 | 1997 | 1460 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 941 | 0.040 |
Why?
| | Histones | 1 | 2024 | 639 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 78 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 827 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 648 | 0.040 |
Why?
| | Indoles | 1 | 2001 | 411 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1976 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 413 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 494 | 0.040 |
Why?
| | Recurrence | 1 | 2021 | 1058 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 198 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 845 | 0.040 |
Why?
| | Pyridines | 1 | 2021 | 504 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.030 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 624 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 12 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 319 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 161 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 1996 | 126 | 0.030 |
Why?
| | Hormones | 1 | 2016 | 143 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 128 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 10 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 176 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 86 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 251 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 399 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1308 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 434 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 84 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 664 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 344 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 523 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 218 | 0.030 |
Why?
| | Anions | 1 | 2013 | 32 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 371 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 152 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 433 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 443 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 295 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 155 | 0.020 |
Why?
| | Heterografts | 1 | 2012 | 139 | 0.020 |
Why?
| | Gene Library | 1 | 2012 | 117 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2110 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1242 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 319 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 175 | 0.020 |
Why?
| | Male | 4 | 2017 | 67308 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 854 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 151 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10768 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 784 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 811 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 12 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5398 | 0.020 |
Why?
| | Transcriptome | 1 | 2012 | 973 | 0.020 |
Why?
| | Prognosis | 1 | 2012 | 4011 | 0.010 |
Why?
| | Liver | 1 | 1992 | 1937 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 2003 | 25 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2003 | 95 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 322 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4281 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2143 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 344 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 387 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 586 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 202 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 599 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 466 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 54 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 127 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 369 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 332 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 346 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 227 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 385 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 981 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 273 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4204 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1679 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|